English
Polski
Español
українська
русский
Antithrombotic drugs in elderly patients
Which antithrombotic drugs should be avoided and which are preferred in elderly patients?
2019-01-31
Which antithrombotic drugs should be avoided and which are preferred in elderly patients?
Should patients receiving anticoagulation treatment carry a special identification card?
What should be the first management steps to be taken immediately upon admission of a patient with bleeding complications of antithrombotic treatment?
Is there still a place for vitamin K antagonists? When can they be used?
How to correctly assess the risk for thrombosis and risk for bleeding when starting or continuing antithrombotic treatment?
In what patients can we consider reducing the duration of lifelong antithrombotic treatment?
What are some of the new trends in the management of thromboembolism?
What anticoagulation treatment should be used in a patient with active cancer and atrial fibrillation after deep vein thrombosis (DVT)?
In what patients treated with vitamin K antagonists should we use perioperative bridging therapy?
In what patients should antithrombotic treatment be continued despite surgery or invasive procedures?
McMaster Textbook of Internal Medicine acknowledges the important contribution of Cochrane Canada and its authors in development of the textbook.